ALX ONCOLOGY HOLDINGS INC 10-K filing
Filed 2026-03-09 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001193125-26-098454
- Form type
- 10-K
- CIK
- 0001810182
- Primary document
- https://www.sec.gov/Archives/edgar/data/1810182/000119312526098454/alxo-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ALX ONCOLOGY HOLDINGS INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-104.0M | - | - |
| Net Income | $-101.7M | - | - |
| Eps Basic | -1.9 | - | - |
| Eps Diluted | -1.9 | - | - |
| Cash And Equivalents | $16.4M | - | - |
| Total Assets | $59.0M | - | - |
| Total Liabilities | $33.1M | - | - |
| Shareholders Equity | $26.0M | - | - |
| Operating Cash Flow | $-84.1M | - | - |
| Capital Expenditures | $212,000 | - | - |